Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DAPT(Dual Antiplatelet Therapy)”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Not applicableStudy completedNCT03197298
What this trial is testing

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting Stents
Thorax Centrum Twente 2,062
Not applicableLooking for participantsNCT05566301
What this trial is testing

Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Who this might be right for
Clopidogrel, Poor Metabolism ofCarotid Stenosis
IRCCS Policlinico S. Donato 1,140
Large-scale testing (Phase 3)Looking for participantsNCT05997693
What this trial is testing

One-Month DAPT in CABG Patients

Who this might be right for
Chronic Coronary Disease
Weill Medical College of Cornell University 700
Not applicableStudy completedNCT03218787
What this trial is testing

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Who this might be right for
Coronary Artery Lesions
Abbott Medical Devices 2,047
Not applicableStudy completedNCT03023020
What this trial is testing

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen

Who this might be right for
High Bleeding RiskCoronary Artery DiseasePCI
ECRI bv 4,579
Not applicableLooking for participantsNCT06075420
What this trial is testing

Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

Who this might be right for
Percutaneous Coronary InterventionDual Antiplatelet Therapy
Genoss Co., Ltd. 1,000
Post-approval studies (Phase 4)Looking for participantsNCT06007222
What this trial is testing

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

Who this might be right for
Aortic StenosisTAVI(Transcatheter Aortic Valve Implantation)Aspirin+2 more
OCEAN-SHD Study Group 400
Post-approval studies (Phase 4)UnknownNCT04116931
What this trial is testing

OPTImal Management of Antithrombotic Agents: OPTIMA-5

Who this might be right for
Acute Coronary Syndrome (ACS)
The First Affiliated Hospital with Nanjing Medical University 80
Post-approval studies (Phase 4)Looking for participantsNCT04436978
What this trial is testing

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionAtrial Fibrillation+8 more
St. Antonius Hospital 2,000
Not applicableStudy completedNCT02516267
What this trial is testing

Evaluation of Platelet Aggregability in the Release of CABG in Patients With ACS With DAPT.

Who this might be right for
Bleeding
University of Sao Paulo General Hospital 190
Not applicableUnknownNCT05770674
What this trial is testing

Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES

Who this might be right for
Coronary Artery Disease
Kiyuk Chang 2,186
Large-scale testing (Phase 3)Not Yet RecruitingNCT07164859
What this trial is testing

Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

Who this might be right for
Coronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)Antiplatelet Therapy+1 more
Vincent ROULE 1,700
Not applicableStudy completedNCT07238764
What this trial is testing

OCT-based DAPT Cessation in HBR Patients

Who this might be right for
High Bleeding Risk PatientsDAPT(Dual Antiplatelet Therapy)Coronary Artery Disease+1 more
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 40
Post-approval studies (Phase 4)Study completedNCT00977938
What this trial is testing

The Dual Antiplatelet Therapy Study (DAPT Study)

Who this might be right for
Coronary Artery Disease
Baim Institute for Clinical Research 25,682
Not applicableLooking for participantsNCT05785897
What this trial is testing

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

Who this might be right for
ST Elevation Myocardial Infarction
IGLESIAS Juan Fernando 350
Post-approval studies (Phase 4)Study completedNCT01995370
What this trial is testing

Cilostazol Stroke Prevention Study for Antiplatelet Combination

Who this might be right for
Noncardioembolic Cerebral Infarction
Japan Cardiovascular Research Foundation 1,884
Not applicableStudy completedNCT03344653
What this trial is testing

Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 2,000
Not applicableNot Yet RecruitingNCT07024446
What this trial is testing

Comparison of Cardiovascular Risks Between Hip Fracture Surgery With Continued DAPT（Dual Antiplatelet Therapy ） Within 6 Weeks vs After 6 Weeks Post-PCI（Percutaneous Coronary Intervention）: A Prospective Observational Cohort Study

Who this might be right for
PCI PatientsDAPT(Dual Antiplatelet Therapy)Hip Fracture Surgeries
Fujian Medical University Union Hospital 50
Not applicableStudy completedNCT03815175
What this trial is testing

XIENCE 28 USA Study

Who this might be right for
Bleeding DisorderIschemic StrokeHemorrhagic Stroke+6 more
Abbott Medical Devices 1,605
Post-approval studies (Phase 4)Study completedNCT02939872
What this trial is testing

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events

Who this might be right for
Percutaneous Transluminal Coronary AngioplastyCoronary Disease
Seung-Jung Park 238
Load More Results